The Efficacy and Safety of Bilastine in the Treatment of Perennial Allergic Rhinitis in Patients with Moderate and Severe Forms of the Disease. Comparison of bilastine 20 mg with desloratadine 5 mg Сергей
Background: Bilastine is a new non-sedating H1 antihistamine approved for the symptomatic treatment of allergic rhinoconjunctivitis (ARC) and urticaria in adults and children over 12 years of age. In this paper, bilastine was compared with desloratadine in the treatment of various forms of allergic...
Main Authors: | S. Ryazantsev, I. Gogunska, I. Lymar, L. Romanyuk, B. Bil, S. Pukhlik, V. Pravdyva, V. Lapshyn, V. Koshlia |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2019-11-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/4409 |
Similar Items
-
Comparative efficacy of bilastine, levocetirizine and desloratadine updosing in chronic urticaria
by: Staevska MT
Published: (2016-11-01) -
Bilastine: A novel antihistamine
by: Jeet Gandhi, et al.
Published: (2018-01-01) -
NEW ORIGINAL ANTIHISTAMINE BILASTINE IN THE TREATMENT OF ALLERGIC RHINITIS
by: A. A. Krivopalov, et al.
Published: (2017-11-01) -
The safety and tolerability profile of bilastine for chronic urticaria in children
by: Nikolaos G. Papadopoulos, et al.
Published: (2019-10-01) -
UV SPECTROPHOTOMETRIC METHOD FOR QUANTITATIVE DETERMINATION OF BILASTINE USING EXPERIMENTAL DESIGN FOR ROBUSTNESS
by: Andressa Tassinari da Silva, et al.
Published: (2017-12-01)